RecruitingNCT04628078
LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
1,000 participants
Start Date
Aug 12, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims at comparing, in a large cohort of consecutive clinically indicated left atrial appendage closure, clinical and imaging outcomes between different subpopulations.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age\> 18
- Written informed consent to participate in the study
- Patients with paroxysmal, persistent, or permanent non-valvular AF and CHA2DS2-VASc Score of ≥2 that are planned for an elective LAA-closure
- Anatomic characteristics allow placement of a CE marked device, dedicated for LAAC
Exclusion Criteria1
- None. Considering the nature of the project, which is to prospectively collect information on all patients treated with LAAC in our center, we will only exclude patients unwilling to sign the informed consent.
Interventions
OTHERUse of echocardiography guidance for LAAC
Since August 2015, the echocardiography is routinely used by majority of operators to guide LAAC
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04628078
Related Trials
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
The CONFORM Pivotal Trial
NCT0514779283 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location